Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 450 across all filing types
Latest filing 2020-06-13 Regulatory Filings
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (163 characters) and contains no substantive content, financial data, or descriptive information. It appears to be metadata or placeholder text without any report or announcement details. Given the lack of content, it cannot be classified as a report or announcement type. According to the rules, such minimal or non-informative content defaults to Regulatory Filings (RNS) as a fallback category.
2020-06-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (177 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, this document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-classifiable filings, which is Regulatory Filings (RNS).
2020-06-09 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, related to shareholding of promoters and persons acting in concert as of March 31, 2020. It is addressed to stock exchanges and contains detailed shareholding information. This type of disclosure corresponds to notifications about major shareholding changes or confirmations, which fits the category of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding under SEBI takeover regulations.
2020-06-03 English
Updates
Regulatory Filings
2020-05-14 English
Appointment
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new Head of Supply Chain Management (Vice President) at Nath Bio Genes (India) Limited. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement), 2015, which pertains to disclosure of material events including management changes. The content focuses on the appointment details, the appointee's profile, and a statement from the Managing Director. There is no financial data, no report attached or referenced, and the document is not a full report or presentation. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2020-05-13 English
Reply to Clarification Sought
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to the National Stock Exchange of India regarding clarification on a previous announcement about the introduction of new cotton hybrids. It provides specific details such as the date of launch, product category, market, and countries of launch. The document is brief (1061 characters) and does not contain any financial statements, detailed financial data, or comprehensive report content. It is an informational clarification related to a prior announcement rather than a full report or financial filing. Given its nature and length, it fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-07 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.